Cordis

Cardinal Health to acquire Johnson & Johnson’s Cordis

Wednesday, March 4, 2015

Johnson & Johnson has received a binding offer from Cardinal Health, a healthcare services company based in Dublin, Ohio, to acquire its Cordis business for an aggregate value of $1.99 billion, consisting of $1.944 billion of cash proceeds from Cardinal Health plus approximately $46 million of retained net receivables. Cordis is a developer and manufacturer of interventional vascular technology with 2014 net revenues of approximately $780 million.

[Read More]

Discovery Labs adds to scientific leadership team

Friday, May 23, 2014

Discovery Laboratories, a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, has strengthened its scientific leadership. Effective immediately, Steve Simonson, M.D., M.H.S., has joined the company as vice president, Clinical Development, and Lawrence Weinstein has joined as vice president, Medical Device Development.

[Read More]